Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 13/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | MAOB | P27338 | 4/20 | 0.53 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA3 | P07451 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29809000 | 1.00 | APP (0.79) | APPCYP1A2MAOBMAOANPC1 | |
| SCHEMBL1093700 | 0.91 | APP (0.67) | APPCYP1A2MAOBMAOANPC1 | |
| SCHEMBL19627050 | 0.89 | APP (0.78) | APPCYP1A2MAOBMAOAACHE | |
| SCHEMBL1104921 | 0.88 | APP (1.00) | APPCYP1A2NPC1MEN1KMT2A | |
| SCHEMBL18467806 | 0.88 | APP (0.80) | APPCYP1A2MAOBMAOANPC1 | |
| SCHEMBL10167879 | 0.88 | APP (0.80) | APPCYP1A2MAOBMAOANPC1 | |
| SCHEMBL19627047 | 0.88 | APP (0.70) | APPCYP1A2 | |
| SCHEMBL10167864 | 0.87 | APP (1.00) | APPCYP1A2MAOBMAOANPC1 | |
| SCHEMBL23623803 | 0.85 | APP (0.78) | APPCYP1A2MAOBMAOANPC1 | |
| SCHEMBL19630615 | 0.85 | APP (0.75) | APPCYP1A2MAOBMAOANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103487412-B | Method for constructing rapid hepatotoxicity predication model of phenolic compound | UNIV SHANGHAI JIAOTONG | 2015-07-15 | — | — | CN | claimed |
| CN-103487412-A | Method for constructing rapid hepatotoxicity predication model of phenolic compound | UNIV SHANGHAI JIAOTONG | 2014-01-01 | — | — | CN | claimed |
| EP-1268848-A2 | MONOOXYGENASE ASSAYS | Aclara BioSciences, Inc. (US) | 2003-01-02 | — | — | EP | claimed |
| WO-2001073113-A2 | MONOOXYGENASE ASSAYS | ACLARA BIOSCIENCES, INC. (US) | 2001-10-04 | — | — | WO | claimed |
| EP-1083223-A1 | NOVEL IMMORTALIZED HEPATIC CELL LINE ORIGINATING IN HUMANS | Takeda Chemical Industries, Ltd. (JP) | 2001-03-14 | — | — | EP | claimed |
| EP-4732010-A1 | MICROFLUIDIC ENZYME ASSAYS | University of Helsinki (FI) | 2026-04-29 | — | — | EP | disclosed |
| EP-4560009-A1 | METHOD FOR THE PREPARATION OF ISOLATED LIVER-DERIVED CELLS | Cellaïon SA (BE) | 2025-05-28 | — | — | EP | disclosed |
| CN-119979693-A | MiRNA as biomarker for Parkinson's disease and diagnostic kit using miRNA | 帕美尔生物技术有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-113293150-B | Mutant enzymes | 牛津大学科技创新有限公司 | 2025-05-13 | — | — | CN | disclosed |
| US-20250113821-A1 | Methods and Compositions for Preserving Tissues and Organs | MASSACHUSETTS GEN HOSPITAL (US) | 2025-04-10 | — | — | US | disclosed |
| US-12239126-B2 | Methods and compositions for preserving tissues and organs | THE GENERAL HOSPITAL CORPORATION (US) | 2025-03-04 | — | — | US | disclosed |
| CN-111344417-B | MiRNA as biomarker for Parkinson's disease and diagnostic kit using miRNA | 国民大学校产学协力团 | 2025-01-28 | — | — | CN | disclosed |
| WO-2001073113-A2 | MONOOXYGENASE ASSAYS | ACLARA BIOSCIENCES, INC. (US) | 2001-10-04 | — | — | WO | disclosed |
| EP-1135521-A2 | METHOD FOR MEASURING ENZYME ACTIVITY BY USING A SIDE REACTION OF SAID ENZYME | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6207404-B1 | SUBJECTING THE CYTOCHROME P450 ENZYME AND THE COUMARIN BASED COMPOUND TO CONDITIONS WHEREBY THE CYTOCHROME P450 ENZYME CATALYZES THE CONVERSION OF THE COUMARIN BASED COMPOUND TO A FLUORESCENT PRODUCT | GENTEST CORPORATION | 2001-03-27 | — | — | US | disclosed |
| EP-1083223-A1 | NOVEL IMMORTALIZED HEPATIC CELL LINE ORIGINATING IN HUMANS | Takeda Chemical Industries, Ltd. (JP) | 2001-03-14 | — | — | EP | disclosed |
| WO-2001014361-A1 | THE USE OF FLUORESCEIN ARYL ETHERS IN HIGH THROUGHPUT CYTOCHROME P450 INHIBITION ASSAYS | GENTEST CORPORATION (US) | 2001-03-01 | — | — | WO | disclosed |
| WO-2001007069-A1 | IN VIVO INDUCTION FOR ENHANCED FUNCTION OF ISOLATED HEPATOCYTES | ORGANOGENESIS INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2000034506-A2 | METHOD OF SCREENING CANDIDATE COMPOUNDS FOR SUSCEPTIBILITY TO OXIDATIVE METABOLISM | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2000-06-15 | — | — | WO | disclosed |
| WO-1992014817-A1 | IN VIVO ASSAY SYSTEMS FOR METABOLIC ROUTES | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1992-09-03 | — | — | WO | disclosed |